Patents by Inventor Andrew Pumerantz

Andrew Pumerantz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL FORMULATION OF PEGYLATED-LIPOSOME ENCAPSULATED GLYCOPEPTIDE ANTIBIOTICS
    Publication number: 20190133946
    Abstract: This invention is directed to a novel method of treating an individual suffering from a bacterial infection, such as bacterial infections of various tissues or organs of an individual. In general, the method of treatment involves administering to an individual a pharmaceutical formulation that comprises a liposome-encapsulated antimicrobial agent, wherein polyethylene glycol (PEG) molecules are covalently attached to the surface of the liposomes.
    Type: Application
    Filed: August 2, 2018
    Publication date: May 9, 2019
    Applicant: WESTERN UNIVERSITY OF HEALTH SCIENCES
    Inventors: Andrew PUMERANTZ, Guru V. BETAGERI, Jinghua Jeffrey WANG
  • NOVEL FORMULATION OF PEGYLATED-LIPOSOME ENCAPSULATED GLYCOPEPTIDE ANTIBIOTICS
    Publication number: 20170231912
    Abstract: This invention is directed to a novel method of treating an individual suffering from a bacterial infection, such as bacterial infections of various tissues or organs of an individual. In general, the method of treatment involves administering to an individual a pharmaceutical formulation that comprises a liposome-encapsulated antimicrobial agent, wherein polyethylene glycol (PEG) molecules are covalently attached to the surface of the liposomes.
    Type: Application
    Filed: January 30, 2017
    Publication date: August 17, 2017
    Applicant: WESTERN UNIVERSITY OF HEALTH SCIENCES
    Inventors: Andrew PUMERANTZ, Guru V. BETAGERI, Jinghua Jeffrey WANG
  • Formulation of PEGylated-liposome encapsulated glycopeptide antibiotics
    Patent number: 9566238
    Abstract: This invention is directed to a novel method of treating an individual suffering from a bacterial infection, such as bacterial infections of various tissues or organs of an individual. In general, the method of treatment involves administering to an individual a pharmaceutical formulation that comprises a liposome-encapsulated antimicrobial agent, wherein polyethylene glycol (PEG) molecules are covalently attached to the surface of the liposomes.
    Type: Grant
    Filed: June 20, 2011
    Date of Patent: February 14, 2017
    Assignee: WESTERN UNIVERSITY OF HEALTH SCIENCES
    Inventors: Andrew Pumerantz, Guru Betageri, Jeffrey Jinghua Wang